Retrieve available abstracts of 16 articles: HTML format
Single Articles
February 2025
PENG X, Lian Z, O'Brien V, Xiao J, et al Foamy monocytes and atherogenesis in mice with combined hyperlipidemia and
effects of antisense knockdown of apoCIII.
J Lipid Res. 2025 Feb 21:100763. doi: 10.1016/j.jlr.2025.100763. PubMedAbstract available
January 2025
WESTBYE AB, Dizdarevic LL, Dahl SR, Asprusten EA, et al A sterol panel for rare lipid disorders: sitosterolemia, cerebrotendinous
xanthomatosis and Smith-Lemli-Opitz syndrome.
J Lipid Res. 2025;66:100698. PubMedAbstract available
November 2024
DUDDU S, Katakia YT, Chakrabarti R, Sharma P, et al New Epigenome Players in the Regulation of PCSK9 - H3K4me3 and H3K9ac Alteration
by Statins in hypercholesterolemia.
J Lipid Res. 2024 Nov 18:100699. doi: 10.1016/j.jlr.2024.100699. PubMedAbstract available
LA CHICA LHOEST MT, Martinez A, Garcia E, Dandurand J, et al ApoB100 Remodeling and Stiffened Cholesteryl Ester Core Raise LDL Aggregation in
Familial Hypercholesterolemia Patients.
J Lipid Res. 2024 Nov 16:100703. doi: 10.1016/j.jlr.2024.100703. PubMedAbstract available
August 2024
JIN Y, Kozan D, Young ED, Hensley M, et al A high-cholesterol zebrafish diet promotes hypercholesterolemia and
fasting-associated liver steatosis.
J Lipid Res. 2024 Aug 30:100637. doi: 10.1016/j.jlr.2024.100637. PubMedAbstract available
July 2024
BARDEY F, Rieck L, Spira D, Marz W, et al Clinical characterization and mutation spectrum of patients with
hypertriglyceridemia in a German outpatient clinic.
J Lipid Res. 2024 Jul 3:100589. doi: 10.1016/j.jlr.2024.100589. PubMedAbstract available
LI C, Tian J, Liu N, Song D, et al MicroRNA-206 as a potential cholesterol-lowering drug is superior to statins in
mice.
J Lipid Res. 2024;65:100576. PubMedAbstract available
June 2024
YANG Y, Konrad RJ, Ploug M, Young SG, et al APOA5 Deficiency Causes Hypertriglyceridemia by Reducing Amounts of Lipoprotein
Lipase in Capillaries.
J Lipid Res. 2024 Jun 14:100578. doi: 10.1016/j.jlr.2024.100578. PubMedAbstract available
JIANG L, Gangireddy S, Dickson AL, Xin Y, et al Characterizing genetic profiles for high triglyceride levels in U.S. patients of
African ancestry.
J Lipid Res. 2024;65:100569. PubMedAbstract available
February 2024
CHACKERIAN B, Remaley AT PCSK9 Vaccines: A promising new strategy for the treatment of
hypercholesterolemia?
J Lipid Res. 2024 Feb 17:100524. doi: 10.1016/j.jlr.2024.100524. PubMed
VROOM MM, Lu H, Lewis M, Thibodeaux BA, et al VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeys.
J Lipid Res. 2024;65:100497. PubMedAbstract available
January 2024
SLIJKHUIS N, Razzi F, Korteland SA, Heijs B, et al Spatial Lipidomics of Coronary Atherosclerotic Plaque Development in a Familial
Hypercholesterolemia Swine Model.
J Lipid Res. 2024 Jan 19:100504. doi: 10.1016/j.jlr.2024.100504. PubMedAbstract available
December 2023
CHAPMAN MJ, Orsoni A, Mellett NA, Nguyen A, et al Statin treatment remodels the HDL subclass lipidome and proteome in
hypertriglyceridemia.
J Lipid Res. 2023 Dec 29:100494. doi: 10.1016/j.jlr.2023.100494. PubMedAbstract available
MEDEIROS AM, Alves AC, Miranda B, Chora JR, et al Unravelling the genetic background of individuals with a clinical Familial
Hypercholesterolemia phenotype.
J Lipid Res. 2023 Dec 18:100490. doi: 10.1016/j.jlr.2023.100490. PubMedAbstract available
JAMES JK, Norland K, Johar AS, Kullo IJ, et al Deep generative models of LDLR protein structure to predict variant
pathogenicity.
J Lipid Res. 2023;64:100455. PubMedAbstract available
July 2023
WANG Y, Kong L, Ye C, Dou C, et al Hypertriglyceridemic hyperapoB and the development and resolution of nonalcoholic
fatty liver disease: A cohort study.
J Lipid Res. 2023 Jul 20:100418. doi: 10.1016/j.jlr.2023.100418. PubMedAbstract available